Showing results (211-220 of 227) with videos related to

Sort By:
Pageof 23
Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Discovery of ANA975: an oral prodrug of the TLR-7 agonist isatoribineAlan X Xiang, Stephen E Webber, Bradley M Kerr, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 20, 2017
[Relationship between glycemic control and visceral adiposity index among the patients with type 2 diabetes mellitus]Y Y Cao, X Tang, K X Sun, et al.
Molecular Cancer Therapeutics|August 5, 2020
The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal MelanomaFlorencia Rago, GiNell Elliott, Ailing Li, et al.
Environmental Science and Pollution Research International|October 21, 2011
The Yangtze-Hydro Project: a Chinese-German environmental programA Bergmann, Y Bi, L Chen, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymeraseSun Hee Kim, Martin T Tran, Frank Ruebsam, et al.
ESMO Open|October 15, 2021
Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancerQ Gou, C Z Zhang, Z H Sun, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2009
5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymeraseDavid A Ellis, Julie K Blazel, Chinh V Tran, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2008
4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymeraseDavid A Ellis, Julie K Blazel, Stephen E Webber, et al.
Nucleic Acids Research|December 6, 2014
BioAssay Research Database (BARD): chemical biology and probe-development enabled by structured metadata and result typesE A Howe, A de Souza, D L Lahr, et al.
CNS Drugs|December 21, 2017
Targeting Neuroinflammation to Treat Alzheimer's DiseaseA Ardura-Fabregat, E W G M Boddeke, A Boza-Serrano, et al.
Pageof 23